Role of Neoadjuvant Immune Checkpoint Inhibitors in Locally Advanced Rectal Cancer: A Systematic Review of Currently Available Studies
Combination therapy with immune checkpoint inhibitors in locally advanced rectal cancer appears to improve treatment response, but high-level evidence and long-term data are still lacking.
Authors
- Alexander G. Heriot (ORCID: https://orcid.org/0000-0001-9846-8776)
- Robert G. Ramsay (ORCID: https://orcid.org/0000-0001-5003-0433)
- Nicholas J. Clemons (ORCID: https://orcid.org/0000-0001-9283-9978)
- Milton Mui (ORCID: https://orcid.org/0000-0002-1507-8228)
- Michael Michael (ORCID: https://orcid.org/0000-0002-0593-2662)
- Joseph C. Kong
Institutions
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- The Alfred Hospital (AU)
Publication Details
- Journal
- Diseases of the Colon & Rectum
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1097/dcr.0000000000003927
- Citations
- 1
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.05